Beijing Dayou Dingxin Investment Management Partnership, L.P. v. Wang

District Court, N.D. Ohio·Decided November 25, 2024·No. 1:24-cv-00137·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

BEIJING DAYOU DINGXIN ) CASE NO. 1:24-cv-137 INVESTMENT MANAGEMENT ) PARTNERSHIP, L.P., et al., ) JUDGE CHARLES E. FLEMING ) Petitioners, ) ) v. ) ) CHAN QIAN WANG, et al., ) MEMORANDUM OPINION AND ) ORDER Respondents. )

Pending before the Court is Petitioners Beijing Dayou Dingxin Investment Management Partnership, L.P. and Suzhou Youtou Cornerstone Enterprise Management Center, L.P.’s Petition to Recognize and Enforce a Foreign Arbitration Award (“Petition”) (ECF No. 1). Respondent Hao Zhou has filed an opposition. (ECF No. 23). For the reasons discussed below, the Petition is GRANTED. I. FACTUAL AND PROCEDURAL BACKGROUND A. The Parties’ Agreement and the Foreign Arbitration Award This matter arises out of a contract dispute between Petitioners and Respondents. On July 31, 2019, Petitioner Beijing Dayou Dingxin Investment Management Partnership, L.P. (“Petitioner 1”) and Petitioner Suzhou Youtou Cornerstone Enterprise Management Center, L.P. (“Petitioner 2”) entered into a Repurchase Agreement with Respondent Chan Qian Wang and Respondent Hao Zhou. (ECF No. 1-1, PageID #68–78). At the time, Petitioner 1 held 9.65% of the shares in ZUGA Medical, Inc. (“U.S. ZUGA”), a United States corporation, while Petitioner 2 held 2.30%. (Id. at PageID #57, 69). Respondents were the founders and controlling parties of U.S. ZUGA. (ECF No. 1, PageID #3; ECF No. 1-1, PageID #70). The Repurchase Agreement contemplated a reorganization of the structure and ownership of U.S. ZUGA and the four businesses controlled by U.S. ZUGA. (ECF No. 1-1, PageID #57, 69–70). The reorganization was to transform U.S. ZUGA into a subsidiary of Rurong (Chengdu) Medical Technology Company, Ltd. (“Chengdu Rurong”), “with the aim of listing Chengdu Rurong in China.” (Id. at PageID #59). After the reorganization, Petitioners’ equity in U.S. ZUGA would have been converted into

equity in Chengdu Rurong and Respondents promised to repurchase 38.85% of Petitioners’ equity in Chengdu Rurong for the amount of 15 million Chinese Yuan by June 30, 2021 (repurchase due date). (Id. at PageID #58–59, 70–71). The Repurchase Agreement also contained the following arbitration provisions: 5.1 In the event of any dispute arising from the performance of this Agreement, the Parties shall resolve the same through amicable consultations; upon failure of such consultations or in the event that either Party or a plurality of Parties shall be unwilling to engage in such consultations, the dispute may be submitted to the China International Economic and Trade Arbitration Commission for resolution through arbitration.

5.2 In the event of relevant costs incurred due to the application for arbitration and engagement of attorneys as a result of any dispute over this Agreement, including but not limited to costs such as arbitration fees, attorneys’ fees, travel expenses and transportation, etc., they shall be borne by the Party in breach.

(Id. at PageID #72–73). The reorganization contemplated under the Repurchase Agreement was completed before the repurchase due date and Petitioner sent a Notice of Demand for Repurchase on April 12, 2021, seeking fulfillment of Respondents’ obligations under the Repurchase Agreement. (Id. at PageID #58–59). After Respondents failed to fulfill their repurchase obligations and efforts to resolve the dispute failed, Petitioners submitted the dispute to the China International Economic and Trade Arbitration Commission (“CIETAC”) for arbitration on July 13, 2021. (Id. at PageID #42). The CIETAC accepted the arbitration case based on the arbitration clauses found in the Repurchase Agreement. (Id. at PageID #42). On August 18, 2022, the CIETAC issued an arbitral award for Petitioners and against Respondents (“Award”). (Id. at PageID #12–67). The Arbitral Tribunal determined that: (i) the Repurchase Agreement was a valid and binding agreement, “which embodied the true meaning of

the parties and did not violate any mandatory provisions of laws and administrative regulations”; and (ii) Respondents had breached the contract by failing to pay the repurchase amount. (Id. at PageID #60–61). The Arbitral Tribunal awarded the following relief: (I) [Respondent Chan Qian Wang and Respondent Hao Zhou] shall jointly and severally pay the Petitioners CNY 15 million to repurchase 38.85% of all equity held by the Petitioners in Rurong (Chengdu) Medical Technology Co., Ltd.

(II) [Respondent Chan Qian Wang and Respondent Hao Zhou] shall jointly and severally pay the late payment fee for the repurchase of the Petitioners’ equity, which shall be calculated on the basis of CNY 15 million at the rate of 10% per annum from July 1, 2021 to the date of actual payoff of the entire repurchase price.

(III) [Respondent Chan Qian Wang and Respondent Hao Zhou] shall jointly and severally pay the attorney’s fee of CNY 100,000 paid by the Petitioners in connection with this case.

(IV) The arbitration fee in this case is CNY 306,000, which shall be borne entirely by [Respondent Chan Qian Wang and Respondent Hao Zhou]. Given that the arbitration fee has been fully offset by the advance payment made by the Petitioners, the [Respondent Chan Qian Wang and Respondent Hao Zhou] shall pay the Petitioners CNY 306,000 in compensation for the arbitration fee paid by the Petitioners on its behalf.

(Id. at PageID #62–63). The Award stated that it was a final award that took immediate effect, and Respondents were to fully pay the award within fifteen days. (Id. at PageID #63). B. Proceedings in Federal Court On January 24, 2024, Petitioners filed the instant action, seeking enforcement of the Award against Respondents Chan Qian Wang and Hao Zhou. (Id. at PageID #6–9). On April 16, 2024, Respondent Wang filed a Notice of Automatic Stay in Bankruptcy, informing the Court of the pendency of Chapter 7 bankruptcy proceedings in the United States Bankruptcy Court for the Northern District of Ohio and a corresponding automatic stay under 11 U.S.C. § 362. (ECF No. 13). On April 25, 2024, Respondent Zhou filed a pro se letter entitled “Answer to Summons In

A Civil Action” which argued that: (i) the Court lacked personal jurisdiction over him; and (ii) the instant petition to enforce an arbitration award was premature. (ECF No. 14). On May 27, 2024, Petitioners responded that Respondent Zhou had provided no evidence to support these assertions and states that they are unaware of any pending proceeding concerning the validity of the arbitration award. (ECF No. 17, PageID #125). On July 1, 2024, Respondent Zhou filed a reply that: (i) requested a stay of the proceeding; (ii) provided screenshots and translations of a text conversation between Respondent Wang and her lawyer, which he argues demonstrate that there is a pending, timely appeal of the arbitration award; and (iii) stated that notarized materials were taking longer than expected and he was “committed” to providing this evidence within two months.

(ECF No. 19; ECF No. 19-1). On July 9, 2024, the Court stayed the case as to Respondent Wang pursuant to 11 U.S.C. § 362(a) and denied Respondent Zhou’s request to dismiss the petition for lack of personal jurisdiction. (ECF No. 20). The Court also denied Respondent Zhou’s request to stay proceedings after finding that Respondent Zhou failed to provide documentation to establish that the Award was non-final. (Id. at PageID #166–68). On August 6, 2024, the stay was lifted after Respondent Wang filed a notice of discharge of bankruptcy. (ECF No. 21; Order [non-document] dated Aug. 6, 2024). The Court ordered Respondents to file their responses to the Petition by August 29, 2024.

Free access — add to your briefcase to read the full text and ask questions with AI

Beijing Dayou Dingxin Investment Management Partnership, L.P. v. Wang, (N.D. Ohio 2024).

Beijing Dayou Dingxin Investment Management Partnership, L.P. v. Wang (Beijing Dayou Dingxin Investment Management Partnership, L.P. v. Wang) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related